Edesa Biotech, Inc. logo

Edesa Biotech, Inc.

NASDAQ:EDSA

Overview | Financials
Company Name Edesa Biotech, Inc.
Symbol EDSA
Currency USD
Price 4.369
Market Cap 14,187,847
Dividend Yield 0%
52-week-range 2.46 - 8.33
Industry Biotechnology
Sector Healthcare
CEO Dr. Pardeep Nijhawan FRCPC, M.D.
Website https://www.edesabiotech.com

An error occurred while fetching data.

About Edesa Biotech, Inc.

Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19

Related Stocks

Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc.

MRKR

2.774 USD

Financials

Numbers are in millions USD

Numbers are in millions USD